Beta blockers
BETA BLOCKERS
Beta-blockers
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Beta-blocker
BETA-BLOCKER ?
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes